Reply
Jan. 31, 2021
Attorney General William Tong today released the third full unredacted complaint filed by a coalition of 51 states and territories resulting from its more than six year antitrust investigation into price-fixing in the generic pharmaceutical industry. The states allege that generic drug manufacturers of topical products conspired to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States. The complaint was unsealed after the court granted the states motion to unseal. Among the evidence unsealed are images from the so-called Diary of Collusion meticulously documenting widespread price-fixing in the generic drug industry. Excerpts from the diary are interwoven throughout the third complaint.